Clinical Trials Directory

Trials / Unknown

UnknownNCT03798925

mNGS for Detection of Pathogens for Pulmonary Infection

Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing for Pulmonary Infection in Clinical Settings

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Sir Run Run Shaw Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Pulmonary infections remain the leading causes of morbidity and mortality among patients worldwide. Pathogen identification is crucial yet difficult for the majority of the cases. Metagenomic Next-generation Sequencing provides a potential technology for rapid and untargeted pathogen detection for pulmonary infection. The study is designed observationally to investigate if mNGS is superior to traditional paradigm of serial tests in the aspect of diagnostic performance. Patients whose primary diagnosis is pulmonary infetion and bronchoalveolar lavage fluid can be obtained will be enrolled. Both mNGS and traditional paradigm of serial tests wil be performed.

Conditions

Interventions

TypeNameDescription
OTHERNone InterventionIt is observational study

Timeline

Start date
2018-08-19
Primary completion
2019-02-01
Completion
2019-02-01
First posted
2019-01-10
Last updated
2019-01-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03798925. Inclusion in this directory is not an endorsement.

mNGS for Detection of Pathogens for Pulmonary Infection (NCT03798925) · Clinical Trials Directory